vs
美国运通（AXP）与百时美施贵宝（BMY）财务数据对比。点击上方公司名可切换其他公司
美国运通的季度营收约是百时美施贵宝的1.6倍（$18.9B vs $11.5B），百时美施贵宝净利率更高（23.3% vs 15.7%，领先7.6%），美国运通同比增速更快（11.4% vs 11.0%），过去两年美国运通的营收复合增速更高（38.8% vs -3.0%）
美国运通是全球知名的支付服务提供商，主营签账卡、信用卡产品及旅行相关服务，下设全球消费者服务、全球商业服务、全球商户与网络服务三大业务板块，还提供支付融资、网络服务、应付账款费用管理、旅行生活服务等多元解决方案。
百时美施贵宝是总部位于美国新泽西州普林斯顿的跨国制药企业，核心产品覆盖多个治疗领域：包括用于心房颤动治疗的艾乐妥（阿哌沙班）、抗癌药物欧狄沃（纳武利尤单抗）、治疗多发性骨髓瘤的瑞复美（来那度胺），以及用于类风湿性关节炎等自身免疫疾病的恩瑞舒（阿巴西普）。
AXP vs BMY — 直观对比
营收规模更大
AXP
是对方的1.6倍
$11.5B
营收增速更快
AXP
高出0.4%
11.0%
净利率更高
BMY
高出7.6%
15.7%
两年增速更快
AXP
近两年复合增速
-3.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $18.9B | $11.5B |
| 净利润 | $3.0B | $2.7B |
| 毛利率 | — | — |
| 营业利润率 | — | — |
| 净利率 | 15.7% | 23.3% |
| 营收同比 | 11.4% | 11.0% |
| 净利润同比 | 15.0% | 8.8% |
| 每股收益（稀释后） | $4.28 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXPBMY
| Q1 26 | $18.9B | $11.5B | ||
| Q4 25 | $10.9B | $12.5B | ||
| Q3 25 | $10.4B | $12.2B | ||
| Q2 25 | $10.3B | $12.3B | ||
| Q1 25 | $9.6B | $11.2B | ||
| Q4 24 | $10.0B | $12.3B | ||
| Q3 24 | $9.7B | $11.9B | ||
| Q2 24 | $9.8B | $12.2B |
净利润AXPBMY
| Q1 26 | $3.0B | $2.7B | ||
| Q4 25 | $2.5B | $1.1B | ||
| Q3 25 | $2.9B | $2.2B | ||
| Q2 25 | $2.9B | $1.3B | ||
| Q1 25 | $2.6B | $2.5B | ||
| Q4 24 | $2.2B | $72.0M | ||
| Q3 24 | $2.5B | $1.2B | ||
| Q2 24 | $3.0B | $1.7B |
毛利率AXPBMY
| Q1 26 | — | — | ||
| Q4 25 | — | 67.2% | ||
| Q3 25 | — | 71.9% | ||
| Q2 25 | — | 72.5% | ||
| Q1 25 | — | 72.9% | ||
| Q4 24 | — | 61.0% | ||
| Q3 24 | — | 75.1% | ||
| Q2 24 | — | 73.2% |
营业利润率AXPBMY
| Q1 26 | — | — | ||
| Q4 25 | 28.2% | 11.8% | ||
| Q3 25 | 36.7% | 25.5% | ||
| Q2 25 | 34.4% | 14.5% | ||
| Q1 25 | 34.6% | 26.5% | ||
| Q4 24 | 27.7% | 1.4% | ||
| Q3 24 | 33.0% | 14.1% | ||
| Q2 24 | 38.6% | 10.5% |
净利率AXPBMY
| Q1 26 | 15.7% | 23.3% | ||
| Q4 25 | 22.5% | 8.7% | ||
| Q3 25 | 27.9% | 18.0% | ||
| Q2 25 | 28.0% | 10.7% | ||
| Q1 25 | 26.8% | 21.9% | ||
| Q4 24 | 21.8% | 0.6% | ||
| Q3 24 | 25.8% | 10.2% | ||
| Q2 24 | 30.7% | 13.8% |
每股收益（稀释后）AXPBMY
| Q1 26 | $4.28 | — | ||
| Q4 25 | $3.52 | $0.54 | ||
| Q3 25 | $4.14 | $1.08 | ||
| Q2 25 | $4.08 | $0.64 | ||
| Q1 25 | $3.64 | $1.20 | ||
| Q4 24 | $3.04 | $0.05 | ||
| Q3 24 | $3.49 | $0.60 | ||
| Q2 24 | $4.15 | $0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $9.6B |
| 总债务越低越好 | $60.4M | $-42.2B |
| 股东权益账面价值 | $34.0M | — |
| 总资产 | $308.9M | — |
| 负债/权益比越低杠杆越低 | 1.78× | — |
8季度趋势，按日历期对齐
现金及短期投资AXPBMY
| Q1 26 | — | $9.6B | ||
| Q4 25 | $742.0M | $10.2B | ||
| Q3 25 | $1.3B | $15.7B | ||
| Q2 25 | $197.0M | $12.6B | ||
| Q1 25 | $261.0M | $10.9B | ||
| Q4 24 | $221.0M | $10.3B | ||
| Q3 24 | $120.0M | $7.9B | ||
| Q2 24 | $188.0M | $6.3B |
总债务AXPBMY
| Q1 26 | $60.4M | $-42.2B | ||
| Q4 25 | $56.4B | $44.8B | ||
| Q3 25 | $57.8B | $48.7B | ||
| Q2 25 | $58.2B | $48.9B | ||
| Q1 25 | $51.2B | $49.5B | ||
| Q4 24 | $49.7B | $49.4B | ||
| Q3 24 | $53.5B | $49.5B | ||
| Q2 24 | $51.5B | $52.0B |
股东权益AXPBMY
| Q1 26 | $34.0M | — | ||
| Q4 25 | $33.5B | $18.5B | ||
| Q3 25 | $32.4B | $18.6B | ||
| Q2 25 | $32.3B | $17.4B | ||
| Q1 25 | $31.2B | $17.4B | ||
| Q4 24 | $30.3B | $16.3B | ||
| Q3 24 | $29.7B | $17.1B | ||
| Q2 24 | $29.5B | $17.0B |
总资产AXPBMY
| Q1 26 | $308.9M | — | ||
| Q4 25 | $300.1B | $90.0B | ||
| Q3 25 | $297.6B | $96.9B | ||
| Q2 25 | $295.6B | $94.7B | ||
| Q1 25 | $282.2B | $92.4B | ||
| Q4 24 | $271.5B | $92.6B | ||
| Q3 24 | $271.0B | $93.7B | ||
| Q2 24 | $272.2B | $94.6B |
负债/权益比AXPBMY
| Q1 26 | 1.78× | — | ||
| Q4 25 | 1.68× | 2.43× | ||
| Q3 25 | 1.78× | 2.63× | ||
| Q2 25 | 1.80× | 2.81× | ||
| Q1 25 | 1.64× | 2.85× | ||
| Q4 24 | 1.64× | 3.03× | ||
| Q3 24 | 1.80× | 2.89× | ||
| Q2 24 | 1.74× | 3.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
